Search for Clinical Trial Results
Keratoconjunctivitis - 62 Studies Found
Status | Study |
Enrolling by invitation |
Study Name: An Open-Label Extension of a Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca Condition: Keratoconjunctivitis Sicca Date: 2016-07-24 Interventions: Drug: OTX-101 0.09% 0.09% cyclosporine nanomicellar solution |
Completed |
Study Name: Study of the Clinical and Biological Efficacity of NAAXIA SINE® in Vernal Keratoconjunctivitis Condition: Keratoconjunctivitis, Vernal Date: 2006-07-26 Interventions: Drug: N-acetyl-aspartyl-glutamate (NAAXIA Sine) |
Completed |
Study Name: Lotemax® Gel 0.5% and Restasis 0.05% in Subjects With Mild or Moderate Keratoconjunctivitis Sicca Condition: Keratoconjunctivitis Sicca Date: 2013-03-21 Interventions:
|
Completed |
Study Name: To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca Condition: Keratoconjunctivitis Sicca Date: 2013-07-11 Interventions:
|
Completed |
Study Name: A Dose-Escalation Study to Assess the Safety and Tolerability of LX214 Ophthalmic Solution in Healthy Volunteers, Followed by an Open-Label Evaluation of LX214 in Patients With Keratoconjunctivitis Sicca (KCS) Condition: Keratoconjunctivitis Sicca Date: 2009-02-24 Interventions: Drug: voclosporin ophthalmic solution 0.02%, 0.2% t.i.d. or b.i.d. |
Completed |
Study Name: Phase III Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis Condition:
Date: 2007-12-03 Interventions:
|
Completed |
Study Name: Effects of Conventional Dry Eye Treatments on the Ocular Surface Response to Low Humidity Environment in Patients With Keratoconjunctivitis Sicca Condition:
Date: 2013-02-21 Interventions: Drug: dexamethasone, artificial tears |
Completed |
Study Name: Efficacy and Safety Study of Nutritional Supplements for Treatments of Dry Eye Condition: Keratoconjunctivitis Sicca Date: 2009-04-17 Interventions:
|
Completed |
Study Name: The Pathogenesis of Superior Limbic Keratoconjunctivitis Condition: Superior Limbic Keratoconjunctivitis Date: 2005-09-12 |
Completed |
Study Name: Phase 2/3 Dose-Ranging Study of the Safety and Efficacy of OTX-101 in the Treatment of Keratoconjunctivitis Sicca Condition:
Date: 2014-09-29 Interventions:
|